Pancreastatin: Multiple Actions on Human Intermediary Metabolismin Vivo, Variation in Disease, and Naturally Occurring Functional Genetic Polymorphism | Zendy

Daniel T. O’Connor | Zendy; Peter E. Cadman | Zendy; Clayton Smiley | Zendy; Rany M. Salem | Zendy; Fangwen Rao | Zendy; Joshua W. Smith | Zendy; Stephen Funk | Zendy; Sushil K. Mahata | Zendy; Manjula Mahata | Zendy; Gen Wen | Zendy; Laurent Taupenot | Zendy; Carmen González-Yanes | Zendy; Kimberly L. Harper | Zendy; Robert R. Henry | Zendy; Vı́ctor Sánchez-Margalet | Zendy

Open Access

Pancreastatin: Multiple Actions on Human Intermediary Metabolismin Vivo, Variation in Disease, and Naturally Occurring Functional Genetic Polymorphism

Author(s) -

Daniel T. O’Connor,

Peter E. Cadman,

Clayton Smiley,

Rany M. Salem,

Fangwen Rao,

Joshua W. Smith,

Stephen Funk,

Sushil K. Mahata,

Manjula Mahata,

Gen Wen,

Laurent Taupenot,

Carmen González-Yanes,

Kimberly L. Harper,

Robert R. Henry,

Vı́ctor Sánchez-Margalet

Publication year - 2005

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2005-0408

Subject(s) - endocrinology , insulin , medicine , in vivo , amino acid , lipolysis , chemistry , biology , biochemistry , adipose tissue , genetics

The chromogranin A (CHGA) fragment pancreastatin (human CHGA250-301) impairs glucose metabolism, but the role of human pancreastatin in vivo remains unexplored.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research